Showing results (281-290 of 381) with videos related to
Sort By:
Pageof 39
Bioactive Materials|June 15, 2022
Oxygen microcapsules improve immune checkpoint blockade by ameliorating hypoxia condition in pancreatic ductal adenocarcinomaJiangchao Wu, Xun Wang, Li Chen, et al.Frontiers in Medicine|July 14, 2020
Liver Injury in Critically Ill and Non-critically Ill COVID-19 Patients: A Multicenter, Retrospective, Observational StudySaiping Jiang, Rongrong Wang, Lu Li, et al.Hepatology Communications|February 9, 2023
Preoperative sintilimab plus transarterial chemoembolization for hepatocellular carcinoma exceeding the Milan criteria: A phase II trialChengxiang Guo, Junlei Zhang, Xin Huang, et al.Nature Cell Biology|May 2, 2022
A non-canonical cGAS-STING-PERK pathway facilitates the translational program critical for senescence and organ fibrosisDan Zhang, Yutong Liu, Yezhang Zhu, et al.The EMBO Journal|January 4, 2023
HERC3 promotes YAP/TAZ stability and tumorigenesis independently of its ubiquitin ligase activityBo Yuan, Jinquan Liu, Aiping Shi, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 9, 2026
Causal Prediction of TP53 Variant Pathogenicity Using a Perturbation-Informed Protein Language ModelHuiying Chen, Yang Zhao, Boqiang Hu, et al.International Journal of Surgery (London, England)|August 27, 2022
Histological tumor micronecrosis in resected specimens after R0 hepatectomy for hepatocellular carcinomas is a factor in determining adjuvant TACE: A retrospective propensity score-matched studyYangyang Wang, Hongbin Ge, Manyi Hu, et al.Cancer Cell|October 10, 2025
Neoadjuvant nab-paclitaxel plus gemcitabine followed by modified FOLFIRINOX for resectable pancreatic cancer: A randomized phase 3 trialXueli Bai, Xiang Li, Yiwen Chen, et al.Annals of Surgical Oncology|July 18, 2022
Comprehensive Clinical Analysis of Gallbladder Neuroendocrine Neoplasms: A Large-Volume Multicenter Study During One DecadeYangyang Wang, Bingfeng Huang, Qihan Fu, et al.Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences|May 12, 2020
[Management of COVID-19: the Zhejiang experience]Kaijin Xu, Hongliu Cai, Yihong Shen, et al.Pageof 39